NPS and Alzheimer disease: Interestingly, somatostatin is the most consistently reduced neuropeptide in the brain and cerebrospinal fluid of AD dementia patients [15], and somatostatin receptor expression was shown to be downregulated in the frontal and temporal cortices of AD brains [75].